Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium. Current status in psychiatric disorders

M Peet1, J P Pratt

  • 1Northern General Hospital, Sheffield, England.

Drugs
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-guided internal jugular vein catheterization: a randomized controlled trial.

Heart, lung and vessels·2014
Same author

Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Commentary on 'The management of treatment-resistant affective disorder: clinical perspectives'.

Journal of psychopharmacology (Oxford, England)·2012
Same author

The ratio of plasma phenylalanine to other large neutral amino acids is not a risk factor for tardive dyskinesia.

Journal of psychopharmacology (Oxford, England)·2012
Same author

The prevention of suicide in patients with recurrent mood disorder.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Antidepressant drug treatment in relation to the use of ECT.

Journal of psychopharmacology (Oxford, England)·2012
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Lithium effectively treats bipolar disorder and mania, and can help with resistant depression. Maintaining specific serum lithium levels (0.5-0.8 mmol/L) balances efficacy with reduced side effects and intoxication risks.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Lithium is a primary treatment for bipolar disorder prophylaxis.
  • Its use in unipolar depression and mania is established, often alongside other medications.
  • Lithium augmentation is a growing strategy for treatment-resistant depression.

Purpose of the Study:

  • To review the established and emerging uses of lithium in psychiatric treatment.
  • To discuss optimal serum concentration ranges and associated adverse effects.
  • To highlight strategies for safe and effective lithium management.

Main Methods:

  • Literature review of lithium's efficacy and safety in psychiatric disorders.
  • Analysis of current clinical practices regarding serum lithium monitoring.
  • Discussion of adverse effects and management strategies.

Related Experiment Videos

Main Results:

  • Lithium is effective for bipolar disorder prophylaxis, mania treatment, and augmenting antidepressants for resistant depression.
  • Maintaining serum lithium concentrations between 0.5-0.8 mmol/L is generally recommended to minimize adverse effects.
  • Common side effects are typically minor and transient; long-term risks like nephrotoxicity and hypothyroidism are uncommon but require monitoring.

Conclusions:

  • Lithium remains a cornerstone treatment for bipolar disorder and offers benefits in other mood disorders.
  • Careful monitoring of serum concentrations and patient education are crucial for optimizing lithium therapy and preventing intoxication.
  • Specialized clinics can enhance the safety and effectiveness of lithium treatment.